Published in Rev Med Brux on September 01, 2006
Culture and end of life care: a scoping exercise in seven European countries. PLoS One (2012) 1.11
A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain. Spine (Phila Pa 1976) (1983) 16.05
Fix what's wrong, not what's right, with general practice in Britain. BMJ (2000) 7.16
Outcome measures for low back pain research. A proposal for standardized use. Spine (Phila Pa 1976) (1998) 6.51
Randomised controlled trial comparing cost effectiveness of general practitioners and nurse practitioners in primary care. BMJ (2000) 6.14
End-of-life decisions in medical practice in Flanders, Belgium: a nationwide survey. Lancet (2000) 4.39
Socioeconomic determinants of rates of consultation in general practice based on fourth national morbidity survey of general practices. BMJ (1996) 4.32
The General Practice Assessment Survey (GPAS): tests of data quality and measurement properties. Fam Pract (2000) 4.06
Socio-economic status of the patient and doctor-patient communication: does it make a difference? Patient Educ Couns (2005) 3.40
Perimenopausal women's views on taking hormone replacement therapy to prevent osteoporosis. BMJ (1990) 3.38
Measuring quality of care with routine data: avoiding confusion between performance indicators and health outcomes. BMJ (1999) 3.25
Understanding controlled trials. Why are randomised controlled trials important? BMJ (1998) 3.25
A study of the natural history of low-back pain. Part II: development of guidelines for trials of treatment in primary care. Spine (Phila Pa 1976) (1983) 2.92
Will changes in primary care improve health outcomes? Modelling the impact of financial incentives introduced to improve quality of care in the UK. Qual Saf Health Care (2004) 2.85
General practice in an age of measurement. Br J Gen Pract (2001) 2.38
New opportunities in practice nursing. BMJ (1995) 2.29
Randomized controlled trial of an educational booklet for patients presenting with back pain in general practice. J R Coll Gen Pract (1989) 2.25
Influence of the presence of doctors-in-training on the blood pressure of patients: a randomised controlled trial in 22 teaching practices. J Hum Hypertens (2004) 1.99
Understanding ethnic and other socio-demographic differences in patient experience of primary care: evidence from the English General Practice Patient Survey. BMJ Qual Saf (2011) 1.92
Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone. J Clin Invest (1974) 1.85
Wet combing for head lice: feasibility in mass screening, treatment preference and outcome. J R Soc Med (2002) 1.82
Clinical governance: bridging the gap between managerial and clinical approaches to quality of care. Qual Health Care (1999) 1.76
Attitudes to risk taking in medical decision making among British, Dutch and Belgian general practitioners. Br J Gen Pract (1990) 1.73
Using health status to measure NHS performance: another step into the dark for the health reform in England. BMJ Qual Saf (2011) 1.70
Is there a case for smaller lists? J R Coll Gen Pract (1987) 1.69
Deputising services. Br Med J (Clin Res Ed) (1984) 1.64
Measuring quality in the NHS: lessons from across the Atlantic. Lancet (1998) 1.63
Oxygen treatment for acute severe asthma. BMJ (2001) 1.60
How valuable is feedback of information on hospital referral patterns? BMJ (1993) 1.59
What makes British general practitioners take part in a quality improvement scheme? J Health Serv Res Policy (2001) 1.59
An educational intervention for front-line health professionals in the assessment and management of suicidal patients (The STORM Project). Psychol Med (2000) 1.59
Factors associated with achieving continuity of care in general practice. J R Coll Gen Pract (1986) 1.57
Socio-demographic inequalities in stage of cancer diagnosis: evidence from patients with female breast, lung, colon, rectal, prostate, renal, bladder, melanoma, ovarian and endometrial cancer. Ann Oncol (2012) 1.54
Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol (1997) 1.52
Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties. J Pharm Pharmacol (1979) 1.50
What is Zelen's design? BMJ (1998) 1.49
Clinical governance in primary care: knowledge and information for clinical governance. BMJ (2000) 1.45
A subtle governance: 'soft' medical leadership in English primary care. Sociol Health Illn (2003) 1.43
Primary care groups: Improving the quality of care through clinical governance. BMJ (2001) 1.43
Doctor-patient communication in different European health care systems: relevance and performance from the patients' perspective. Patient Educ Couns (2000) 1.29
Antidepressants for non-specific low back pain. Cochrane Database Syst Rev (2008) 1.27
Communication in general practice: differences between European countries. Fam Pract (2003) 1.23
How will primary care groups work? BMJ (1998) 1.22
Use of blood tests in general practice: a collaborative study in eight European countries. Eurosentinel Study Group. Br J Gen Pract (1995) 1.17
The British version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol (2001) 1.14
Long-term follow-up in outpatient clinics. 1: The view from general practice. Fam Pract (1997) 1.11
Nurse-led telephone-advice lines. Lancet (1999) 1.11
Getting research into practice. J Epidemiol Community Health (1995) 1.08
Impact of the transition from a conventional to an integrated contextual medical curriculum on students' learning patterns: a longitudinal study. Med Teach (2009) 1.06
Is GP-patient communication related to their perceptions of illness severity, coping and social support? Soc Sci Med (2002) 1.04
Liver and bile duct pathology following Cryptosporidium parvum infection of immunodeficient mice. Hepatology (1999) 1.03
Variation in reported experience of involvement in cancer treatment decision making: evidence from the National Cancer Patient Experience Survey. Br J Cancer (2013) 1.03
Tissue distribution of antitumor drugs associated with polyalkylcyanoacrylate nanoparticles. J Pharm Sci (1980) 1.02
Common patterns of morbidity and multi-morbidity and their impact on health-related quality of life: evidence from a national survey. Qual Life Res (2014) 1.02
Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures. Clin Exp Immunol (1994) 1.01
Acid and pepsin secretion in duodenal ulcer patients in response to graded doses of pentagastrin or pentagastrin and carbacholine before and after proximal gastric vagotomy. Scand J Gastroenterol (1974) 1.00
Toxicity of polyalkylcyanoacrylate nanoparticles II: Doxorubicin-loaded nanoparticles. J Pharm Sci (1982) 0.99
Getting research into practice. J Eval Clin Pract (1997) 0.97
Interferon-gamma is required for innate immunity to Cryptosporidium parvum in mice. J Infect Dis (2000) 0.97
What is the role of quality circles in strategies to optimise antibiotic prescribing? A pragmatic cluster-randomised controlled trial in primary care. Qual Saf Health Care (2007) 0.95
Which bacteria are found in Belgian women with uncomplicated urinary tract infections in primary health care, and what is their susceptibility pattern anno 95-96? Acta Clin Belg (1998) 0.94
Effect of carbacholine and urecholine on pentagastrin-stimulated gastric secretion in healthy subjects. Scand J Gastroenterol (1975) 0.93
Herpes simplex virus interferes with monocyte accessory cell function. J Immunol (1993) 0.93
Comparison of nephrotoxicities of different polyoxyethyleneglycol formulations of amphotericin B in rats. Antimicrob Agents Chemother (1992) 0.92
Intensive and prolonged health promotion strategy may increase awareness of osteoporosis among postmenopausal women. Osteoporos Int (2001) 0.91
Tuboplasty in 130 patients. Improved results due to stents and preoperative endoscopy. Obstet Gynecol (1972) 0.91
Potential population impact of the UK government strategy for reducing the burden of coronary heart disease in England: comparing primary and secondary prevention strategies. Qual Saf Health Care (2006) 0.91
Case-control study of hazards in the home and risk of falls and hip fractures. Age Ageing (1996) 0.90
A seven-year follow-up of proximal gastric vagotomy. Clinical results. Scand J Gastroenterol (1979) 0.90
Proximal gastric vagotomy and pyloroplasty for duodenal ulcer with pyloric stenosis: a thirteen-year experience. World J Surg (1985) 0.90
Molecular weights of free and drug-loaded nanoparticles. Pharm Res (1985) 0.89
In vivo uptake of polyisobutyl cyanoacrylate nanoparticles by rat liver Kupffer, endothelial, and parenchymal cells. J Pharm Sci (1984) 0.89
Gastric secretory response to graded doses of pentagastrin alone or in combination with carbacholine in unoperated duodenal ulcer patients. Scand J Gastroenterol (1975) 0.89
The influence of Myrj 59 on the solubility, toxicity and activity of amphotericin B. J Pharm Pharmacol (1991) 0.88
Treatment-dependent loss of polyfunctional CD8+ T-cell responses in HIV-infected kidney transplant recipients is associated with herpesvirus reactivation. Am J Transplant (2009) 0.88
Is follow up by specialists routinely needed after elective surgery? A controlled trial. J Epidemiol Community Health (1999) 0.88
Cytokine production in varicella-zoster virus-stimulated cultures of human blood lymphocytes. J Infect Dis (1998) 0.88
Adsorption of antineoplastic drugs to polyalkylcyanoacrylate nanoparticles and their release in calf serum. J Pharm Sci (1979) 0.88
Toxicity of polyalkylcyanoacrylate nanoparticles I: Free nanoparticles. J Pharm Sci (1982) 0.88
The pancreatic exocrine secretion in duodenal ulcer patients before and after selective proximal vagotomy of the stomach. Scand J Gastroenterol (1974) 0.87
The potential of the inventory of learning styles to study students' learning patterns in three types of medical curricula. Med Teach (2008) 0.87
Prevention of sperm migration into the uterine cavity by a microdose progestagen. Fertil Steril (1970) 0.87
Eradication of Cryptosporidium parvum infection by mice with ovalbumin-specific T cells. Infect Immun (2000) 0.87
Population impact of stricter adherence to recommendations for pharmacological and lifestyle interventions over one year in patients with coronary heart disease. J Epidemiol Community Health (2005) 0.87
[Perforated ulcer]. Tidsskr Nor Laegeforen (1983) 0.86
Degradation of poly (isobutyl cyanoacrylate) nanoparticles. Biomaterials (1984) 0.86
Long-term follow-up in outpatient clinics. 2: The view from the specialist clinic. Fam Pract (1997) 0.85
Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles. Cancer Chemother Pharmacol (1990) 0.85
Nanocapsules: a new type of lysosomotropic carrier. FEBS Lett (1977) 0.84
Serum gastrin and gastric acid secretion before and after proximal gastric vagotomy. Scand J Gastroenterol (1974) 0.84
Effect of urecholine and carbacholine on pentagastrin-stimulated gastric secretion after proximal gastric vagotomy in duodenal ulcer patients;. Scand J Gastroenterol (1975) 0.84
Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients. Am J Transplant (2014) 0.84
T cell proliferative response to interleukin 2: different frequency of responders among CD45R0 and CD45RA subsets. Cell Immunol (1990) 0.83
Referrals between specialists in hospital outpatient departments. Health Trends (1995) 0.83
Marrow-derived CD40-positive cells are required for mice to clear Cryptosporidium parvum infection. Infect Immun (2001) 0.83
Long-term results after excision of fixed subaortic stenosis. J Thorac Cardiovasc Surg (1985) 0.83
Macrophage activation by polymeric nanoparticles of polyalkylcyanoacrylates: activity against intracellular Leishmania donovani associated with hydrogen peroxide production. Pharm Res (1992) 0.82
Varicella-zoster virus (VZV)-specific cytotoxicity after immunization of nonimmune adults with Oka strain attenuated VZV vaccine. J Infect Dis (1992) 0.82